What Expanded ASCO BRCA1/2 Mutation Testing Guidelines Mean for Your Cancer Center
What happens when many more breast cancer patients are suddenly eligible for services that are already in high demand? A much larger pool of patients...
What happens when many more breast cancer patients are suddenly eligible for services that are already in high demand? A much larger pool of patients...
In a recent webinar hosted by the Association of Cancer Executives, CancerIQ’s Senior Vice President of Commercial Strategy, John Hansel, discussed...
Genomics has an established benefit in precision cancer care for patients and providers alike – but its positive financial impact on your health...
Digital health innovation is messy, gritty, iterative, and most importantly, it takes place across the healthcare ecosystem.
Learn how a cancer genetic counseling program was able to convert more referrals, improve productivity, and drive downstream revenues.
Software screening solutions remove the obstacles and paperwork that impede breast cancer risk assessment workflows.